title: Small-cell lung cancer in 2016: Shining light on novel targets and therapies.
authors.affiliation: Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; and at the Weill Cornell Medical College, New York, New York, USA.
authors.forename: Charles M
authors.initials: CM
authors.lastname: Rudin
authors.affiliation: Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; and at the Weill Cornell Medical College, New York, New York, USA.
authors.forename: John T
authors.initials: JT
authors.lastname: Poirier
mesh_terms: D000818:Animals; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis / Q000037:antagonists & inhibitors; D059447:Cell Cycle Checkpoints / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008175:Lung Neoplasms / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D051379:Mice; D009362:Neoplasm Metastasis / Q000235:genetics; D055752:Small Cell Lung Carcinoma / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology
chemical_list: D000074322:Antineoplastic Agents, Immunological; D014408:Biomarkers, Tumor; C496666:DLL3 protein, human; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins